Bioactive Sphingolipids as Major Regulators of Coronary Artery Disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, Jae-Hwi | - |
dc.contributor.author | Kim, Goon-Tae | - |
dc.contributor.author | Park, Kyung-Ho | - |
dc.contributor.author | Park, Woo-Jae | - |
dc.contributor.author | Park, Tae-Sik | - |
dc.date.accessioned | 2021-07-14T00:40:10Z | - |
dc.date.available | 2021-07-14T00:40:10Z | - |
dc.date.created | 2021-07-01 | - |
dc.date.issued | 2021-05 | - |
dc.identifier.issn | 1976-9148 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/81664 | - |
dc.description.abstract | Atherosclerosis is the deposition of plaque in the main arteries. It is an inflammatory condition involving the accumulation of macrophages and various lipids (low-density lipoprotein [LDL] cholesterol, ceramide, S1P). Moreover, endothelial cells, macrophages, leukocytes, and smooth muscle cells are the major players in the atherogenic process. Sphingolipids are now emerging as important regulators in various pathophysiological processes, including the atherogenic process. Various sphingolipids exist, such as the ceramides, ceramide-1-phosphate, sphingosine, sphinganine, sphingosine-1-phosphate (S1P), sphingomyelin, and hundreds of glycosphingolipids. Among these, ceramides, glycosphingolipids, and S1P play important roles in the atherogenic processes. The atherosclerotic plaque consists of higher amounts of ceramide, glycosphingolipids, and sphingomyelin. The inhibition of the de novo ceramide biosynthesis reduces the development of atherosclerosis. S1P regulates atherogenesis via binding to the S1P receptor (S1PR). Among the five S1PRs (S1PR1-5), S1PR1 and S1PR3 mainly exert anti-atherosclerotic properties. This review mainly focuses on the effects of ceramide and S1P via the S1PR in the development of atherosclerosis. Moreover, it discusses the recent findings and potential therapeutic implications in atherosclerosis. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 한국응용약물학회 | - |
dc.relation.isPartOf | Biomolecules & Therapeutics | - |
dc.title | Bioactive Sphingolipids as Major Regulators of Coronary Artery Disease | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000668020200003 | - |
dc.identifier.doi | 10.4062/biomolther.2020.218 | - |
dc.identifier.bibliographicCitation | Biomolecules & Therapeutics, v.29, no.4, pp.373 - 383 | - |
dc.identifier.kciid | ART002727161 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85110111426 | - |
dc.citation.endPage | 383 | - |
dc.citation.startPage | 373 | - |
dc.citation.title | Biomolecules & Therapeutics | - |
dc.citation.volume | 29 | - |
dc.citation.number | 4 | - |
dc.contributor.affiliatedAuthor | Song, Jae-Hwi | - |
dc.contributor.affiliatedAuthor | Kim, Goon-Tae | - |
dc.contributor.affiliatedAuthor | Park, Woo-Jae | - |
dc.contributor.affiliatedAuthor | Park, Tae-Sik | - |
dc.subject.keywordAuthor | Sphingolipid | - |
dc.subject.keywordAuthor | Ceramide | - |
dc.subject.keywordAuthor | Sphingosine 1-phosphate | - |
dc.subject.keywordAuthor | Sphingosine-1-phosphate receptor | - |
dc.subject.keywordAuthor | Atherosclerosis | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.